Boronic acid derivatives of resveratrol for activating deacetylase enzymes
US10478445B2 · kind B2 · utility
5Cited by
14References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2014 |
| Grant date | Nov 19, 2019 |
| Priority date | — |
| Expiry date | Jul 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compounds, compositions and methods for the treatment of a disease or disorder related to activation of deacetylase enzymes. The compounds and methods are related to boronic acid derivatives of resveratrol. In some forms, the compound, compositions and methods relate to treatment of prostate cancer, colon cancer, or breast cancer, a cardiovascular disease, inflammation, obesity, diabetes, or a neurodegenerative disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.